Previous Close | 1.3400 |
Open | 1.3200 |
Bid | 1.3200 x 900 |
Ask | 1.3700 x 1400 |
Day's Range | 1.3150 - 1.3750 |
52 Week Range | 0.9700 - 4.1200 |
Volume | |
Avg. Volume | 1,215,320 |
Market Cap | 107.945M |
Beta (5Y Monthly) | 1.48 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.8500 |
Earnings Date | Dec 11, 2023 - Dec 22, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 8.80 |
Subscribe to Yahoo Finance Plus to view Fair Value for OGI
Rapper Snoop Dogg announced on Nov. 17 that he was giving up smoking cannabis. Cannabis stocks fell on the news. “After much consideration & conversation with my family, I’ve decided to give up smoke. Please respect my privacy at this time,” Newsweek reported Snoop Dogg’s comments from X and Instagram. As anyone who’s followed cannabis stocks over the past few years knows, while the entertainer is a big participant in the industry both as an entrepreneur and user, cannabis problems are far bigge
In an August 2023 column, I wrote “With the chances of marijuana companies accessing the U.S. financial system higher than ever and cannabis stocks trading at lower valuations than ever before, now looks like an excellent time to seek out top-notch cannabis stocks to buy.” I also identified three cannabis companies with very attractive valuations and strong outlooks. However, despite the fact that cannabis stocks in general had tumbled over 90% from their February 2021 peak as of October 2023, t
TORONTO, November 28, 2023--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that Phylos Bioscience Inc. ("Phylos"), a U.S. cannabis genetics company and provider of production ready seeds, has achieved the first milestone under the loan agreement entered into in May 2023 (the "Loan Agreement") and has closed the second tranche under the Loan Agreement with Organigram advancing US$2.75 million to Phylos.